Overview

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Status:
Not yet recruiting

Trial end date:
2025-01-01

Target enrollment:

Participant gender:

Summary

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Phase:

Phase 3

Details

Lead Sponsor:

Kowa Research Institute, Inc.